rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2008-4-24
|
pubmed:abstractText |
Contrast-induced nephropathy (CIN) is at present the third leading cause of hospital-acquired acute kidney injury (AKI). Traditionally, it is diagnosed by measuring the increase of the serum creatinine concentration. However, in patients with acute changes in their glomerular filtration rate, serum creatinine is an insensitive marker. This clinical study was designed to investigate whether human urinary interleukin-18 (IL-18) and neutrophil gelatinase-associated lipocalin (NGAL) are early predictive markers for AKI after coronary angiography and their correlation with later cardiac events.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:issn |
1660-2110
|
pubmed:author |
|
pubmed:copyrightInfo |
Copyright 2008 S. Karger AG, Basel.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
108
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
c176-81
|
pubmed:meshHeading |
pubmed-meshheading:18287807-Acute-Phase Proteins,
pubmed-meshheading:18287807-Aged,
pubmed-meshheading:18287807-Biological Markers,
pubmed-meshheading:18287807-Contrast Media,
pubmed-meshheading:18287807-Coronary Angiography,
pubmed-meshheading:18287807-Humans,
pubmed-meshheading:18287807-Interleukin-18,
pubmed-meshheading:18287807-Iopamidol,
pubmed-meshheading:18287807-Kidney Diseases,
pubmed-meshheading:18287807-Lipocalins,
pubmed-meshheading:18287807-Male,
pubmed-meshheading:18287807-Prognosis,
pubmed-meshheading:18287807-Proto-Oncogene Proteins,
pubmed-meshheading:18287807-Reproducibility of Results,
pubmed-meshheading:18287807-Risk Assessment,
pubmed-meshheading:18287807-Risk Factors,
pubmed-meshheading:18287807-Sensitivity and Specificity
|
pubmed:year |
2008
|
pubmed:articleTitle |
Urinary IL-18 and NGAL as early predictive biomarkers in contrast-induced nephropathy after coronary angiography.
|
pubmed:affiliation |
Renal Division, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
|
pubmed:publicationType |
Journal Article,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|